Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Citizens, Inc. (NYSE:CIA) Pulls Back Even as Its Insurance Business Keeps Growing

● Citizens reported continued growth in its insuranceBusinessin its second-quarter 2026 results, including higher insurance-in-force and net income.

Nitika (Guest) | 31 August 2026

Collegium Pharmaceutical (NASDAQ:COLL) Slides Despite ADHD Portfolio Surge

● Collegium reported second-quarter 2026Revenueof about $199.9 million, with its ADHD portfolio surging.

Nitish Kishor | 31 August 2026

Citius Pharmaceuticals (NASDAQ:CTXR) Slides as Losses Continue to Outpace Sales

● Citius reported LYMPHIR productRevenueof about $1.49 million in its fiscal third-quarter 2026 results, with the product now available at 44 oncology centers.

Nitish Kishor | 31 August 2026

Equifax (NYSE:EFX) Climbs as Data and Analytics Growth Accelerates

● Equifax reported second-quarter 2026Revenuegrowth of about 11%, beating estimates, driven by strength in U.S. Information Solutions and mortgage-related businesses.

Nitish Kishor | 31 August 2026

Advantage Solutions (NASDAQ:ADV) Rallies Even as Margin Pressure Persists

● Advantage Solutions reported second-quarter 2026Revenuegrowth of about 1.8% year over year, beating revenue estimates.

Nitish Kishor | 31 August 2026

Gibraltar Industries (NASDAQ:ROCK) Cools Off Despite a Sleeper-Stock Case

● Gibraltar reported second-quarter 2026 net sales of about $509.5 million, up 64.6% year over year, driven primarily by its OmniMax acquisition.

Nitish Kishor | 31 August 2026

Varonis Systems (NASDAQ:VRNS) Pulls Back Even After Beating Expectations

● Varonis reported second-quarter 2026 SaaS annualRecurring Revenueof about $726 million, up about 52% year over year, with total ARR of about $742 million, up about 18%.

Nitish Kishor | 31 August 2026

Is Waystar Holding (NASDAQ:WAY) Coiling for a Bigger Breakout?

● Waystar reported second-quarter 2026Revenueof about $319.7 million, up 18% year over year, withNet Incomeof about $40.9 million.

Nitish Kishor | 31 August 2026

GeneDx Holdings (NASDAQ:WGS) Cools Off Even as Test Volume Hits a Record

● GeneDx reported second-quarter 2026Revenueof about $114.4 million, up 11% year over year, with record test volume.

Nitish Kishor | 31 August 2026

PDD Holdings (NASDAQ:PDD) Rebounds Despite a Profit Decline

● PDD reported second-quarter 2026Revenuegrowth alongside a net-profit decline of about 12%, though results beat expectations.

Nitish Kishor | 31 August 2026
Support

Hi! How can we help you today?

Loading…